Valium and Brilinta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valium (diazepam) and Brilinta (ticagrelor). Common drug interactions include drug ineffective among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Valium and Brilinta. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Valium?

Valium has active ingredients of diazepam. It is often used in stress and anxiety. eHealthMe is studying from 48,647 Valium users. Check the latest studies of Valium.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.



On Jul, 19, 2026

38 people who take Valium and Brilinta together, and have interactions are studied.

Valium and Brilinta drug interactions.

What are the common drug interactions of Valium and Brilinta, by gender? *:

female:

  1. Drug ineffective
  2. Fall
  3. Hypertension (high blood pressure)
  4. Hypotension (abnormally low blood pressure)
  5. Limb discomfort (discomfort in leg)
  6. Local swelling (swelling at the site of some application of substance or injury)
  7. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  8. Migraine (headache)
  9. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  10. Nervousness

male:

  1. Anaemia (lack of blood)
  2. Blood triglycerides increased
  3. Blood potassium increased
  4. Blood sodium increased
  5. Blood urea increased
  6. Carbon dioxide decreased
  7. Chronic kidney disease
  8. Deafness
  9. Diabetic coma
  10. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)

What are the common drug interactions of Valium and Brilinta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diabetic coma
  2. Blindness
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Coma (state of unconsciousness lasting more than six hours)
  5. Fatigue (feeling of tiredness)
  6. Hypertension (high blood pressure)
  7. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  8. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  9. Vitamin d deficiency
  10. Asthenia (weakness)

50-59:

  1. Lymphocyte count decreased
  2. Muscular weakness (muscle weakness)
  3. Nausea (feeling of having an urge to vomit)
  4. Nerve injury
  5. Neuropathic arthropathy (a progressive destruction of bone and joints)
  6. Neuropathy peripheral (surface nerve damage)
  7. Oedema peripheral (superficial swelling)
  8. Overdose
  9. Overweight
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

60+:

  1. Diarrhoea
  2. Weight decreased
  3. Dizziness
  4. Drug ineffective
  5. Fall
  6. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  7. Haematuria (presence of blood in urine)
  8. Hypotension (abnormally low blood pressure)
  9. Limb discomfort (discomfort in leg)
  10. Local swelling (swelling at the site of some application of substance or injury)

What are the existing conditions these people have? *

  1. High Blood Pressure: 9 people, 23.68%
  2. Pain: 8 people, 21.05%
  3. Essential Thrombocythaemia (chronic blood cancer): 7 people, 18.42%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 13.16%
  5. Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 13.16%
  6. Bipolar Disorder (mood disorder): 5 people, 13.16%
  7. Cardiac Disorder: 5 people, 13.16%
  8. Nausea (feeling of having an urge to vomit): 5 people, 13.16%
  9. Muscle Spasms (muscle contraction): 5 people, 13.16%
  10. High Blood Cholesterol: 5 people, 13.16%

* Approximation only. Some reports may have incomplete information.

Do you take Valium and Brilinta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valium and Brilinta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Brilinta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Brilinta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diazepam and ticagrelor (the active ingredients of Valium and Brilinta, respectively), and Valium and Brilinta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: